Neither study showed a significant increase in amylase (7% for both studies) or lipase (28% in the LEADER trial and 31% in the SCALE trial) values after starting liraglutide compared with placebo, and the positive predictive values of amylase and lipase for pancreatitis were less than 1%
The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater
You can also track your meals, vomiting episodes, missed work, urgent care visits and any test results
For researchers serious about optimizing their protocols, SeekPeptides provides comprehensive dosing resources, evidence-based guides, and tools that eliminate guesswork from every step of the process
You have a body mass index of 27 or more with a weight-related complication, such as high blood pressure and high cholesterol